Article
An Evaluation of Central Sensitization in Patients With Sickle Cell Disease.
The journal of pain - 1 May 2016
Campbell Claudia M, Moscou-Jackson Gyasi, Carroll C Patrick, Kiley Kasey, Haywood Carlton, Lanzkron Sophie, Hand Matthew, Edwards Robert R, Haythornthwaite Jennifer A
Abstract excerpt
UNLABELLED: Central sensitization (CS), nociceptive hyperexcitability known to amplify and maintain clinical pain, has been identified as a leading culprit responsible for maintaining pain in several chronic pain conditions. Recent evidence suggests that it may explain differences in the symptom experience of individuals with sickle cell disease (SCD). Quantitative sensory testing (QST) can be used to examine CS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
